TY - JOUR
T1 - Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin
AU - Mills, G. B.
AU - Lee, J. W.W.
AU - Cheung, R. K.
AU - Gelfand, E. W.
PY - 1985/12/1
Y1 - 1985/12/1
N2 - To characterize the requirements for T cell proliferation, we have studied the response of purified populations of human T cells to varying concentrations of the mitogen phytohemagglutinin (PHA). Concentrations of PHA which induce optimal proliferative responses induce increases in cytosolic free calcium ([Ca2+](i)), expression of interleukin 2 (IL 2) receptors, and production of IL 2. As the concentration of PHA is decreased, each of these processes decreases in parallel. At suboptimal concentrations of PHA, the addition of exogenous IL 2 reconstitutes both the proliferative response and the expression of the IL 2 receptor, as measured by immunofluorescence with antibodies directed against the TAC/IL 2 receptor molecule, but without reconstituting the increase in [Ca2+](i). Therefore, the concentration dependence of responses to PHA appears to be secondary to an absence of IL 2 production due to a failure to induce an increase in [Ca2+](i). The addition of the calcium ionophores A23187 and ionomycin or of accessory cells to low concentrations of PHA induces increases in [Ca2+](i) and subsequent proliferative responses, suggesting that the two events are linked. The proliferative response can be inhibited by antibodies directed towards IL 2 or the IL 2 receptor, indicating that the proliferative response was at least partially dependent on the production and action of IL 2. This suggests that, although increases in [Ca2+](i) are an integral event in the induction of proliferation by PHA, the increase in [Ca2+](i) is required for the production but not the action of IL 2. In addition, low concentrations of PHA deliver an additional signal to cells, independent of an increase in [Ca2+](i), which induces IL 2 receptor expression and allows a proliferative response in the presence of exogenous IL 2.
AB - To characterize the requirements for T cell proliferation, we have studied the response of purified populations of human T cells to varying concentrations of the mitogen phytohemagglutinin (PHA). Concentrations of PHA which induce optimal proliferative responses induce increases in cytosolic free calcium ([Ca2+](i)), expression of interleukin 2 (IL 2) receptors, and production of IL 2. As the concentration of PHA is decreased, each of these processes decreases in parallel. At suboptimal concentrations of PHA, the addition of exogenous IL 2 reconstitutes both the proliferative response and the expression of the IL 2 receptor, as measured by immunofluorescence with antibodies directed against the TAC/IL 2 receptor molecule, but without reconstituting the increase in [Ca2+](i). Therefore, the concentration dependence of responses to PHA appears to be secondary to an absence of IL 2 production due to a failure to induce an increase in [Ca2+](i). The addition of the calcium ionophores A23187 and ionomycin or of accessory cells to low concentrations of PHA induces increases in [Ca2+](i) and subsequent proliferative responses, suggesting that the two events are linked. The proliferative response can be inhibited by antibodies directed towards IL 2 or the IL 2 receptor, indicating that the proliferative response was at least partially dependent on the production and action of IL 2. This suggests that, although increases in [Ca2+](i) are an integral event in the induction of proliferation by PHA, the increase in [Ca2+](i) is required for the production but not the action of IL 2. In addition, low concentrations of PHA deliver an additional signal to cells, independent of an increase in [Ca2+](i), which induces IL 2 receptor expression and allows a proliferative response in the presence of exogenous IL 2.
UR - http://www.scopus.com/inward/record.url?scp=0022202935&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022202935&partnerID=8YFLogxK
M3 - Article
C2 - 2995486
AN - SCOPUS:0022202935
SN - 0022-1767
VL - 135
SP - 3087
EP - 3093
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -